IP Basics

Hearing for Novartis Glivec case

Patents on pharmaceuticals are a contentious issue for many countries around the world, for the obvious reason that the average person in most countries can’t afford to pay for brand-name drugs. The patent battle over Glivec is, needless to say, bitter and complicated. The argument for providing a patent to glivec (imatinib mesylate), a [...]

By |2017-09-07T13:22:56+05:30September 15th, 2012|Patent, IP Basics|0 Comments

ICC in fair deal lawsuit

Today I present to you a case of copyright infringement that deals with fair dealing aspect of Copyright Act, 1957. This is the case between ICC owned subsidiary(Plaintiff No. 1) and a sports broadcasting and content provider which delivers various international and regional sports contents to viewers via its sports channels(Plaintiff No. 2) with [...]

By |2017-09-07T13:22:23+05:30September 13th, 2012|IP Basics, Patent|0 Comments

Barfi in trouble!

As the public awaits for the new film by Ranbir Kapoor, titled “Barfi”, the movies goes into a legal trouble. The British firm Murphy enterprise which owns Murphy radios have sent a legal notice to UTV Motion Pictures for the use of Murphy's name in the title track “Ala barfi” without the consent of [...]

By |2017-09-07T13:21:20+05:30September 13th, 2012|IP Basics|0 Comments

IPAB holds an important decision on compulsory license for cancer drug ‘Nexavar’

Compulsory license makes it compulsory for the owner of a patent to license the use of their rights against payment either set by law or determined by arbitration. A company seeking to use a patent can do so without seeking the patent holder's consent, and pays the patent holder a set fee for the [...]

By |2017-09-07T13:20:14+05:30September 8th, 2012|IP Basics|0 Comments
Go to Top